Annual Cash & Cash Equivalents
$1.93B$980.00M-33.71%
Summary
- Current Value
- As of today, MRNA annual cash & cash equivalents is $1.93B, down -33.71% on
- Historical Performance
- MRNA annual cash & cash equivalents is down -71.86% over the past 3 years, and up +716.95% over the past 5 years
- All-Time High Comparison
- MRNA annual cash & cash equivalents is currently -71.86% below its historical high of $6.85B set on
- 3-Year Low Comparison
- MRNA annual cash & cash equivalents is at its 3-year low
- Sector Comparison
- MRNA annual cash & cash equivalents is higher than 95.67% of companies in Healthcare sector
Cash and Cash Equivalents Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash & Cash Equivalents | $1.93B | -33.7% | -71.9% | +717.0% | +10000.0% | |
| Quarterly Cash & Cash Equivalents | $4.51B | -34.4% | -46.0% | +37.5% | +10000.0% | |
| Price | $33.84 | -19.9% | -82.0% | -72.8% | – | |
| Annual Current Assets | $8.10B | -21.6% | -49.6% | +617.5% | +10000.0% | |
| Annual Total Liabilities | $3.24B | -29.1% | -69.8% | +681.7% | +10000.0% | |
| Annual Working Capital | $5.89B | -19.4% | -15.1% | +497.9% | +10000.0% | |
| Annual Net Income | -$3.56B | +24.5% | -129.2% | -592.8% | -10000.0% |
Cash and Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $3.21B | N/A | -39.9% |
| 5Y | $6.85B | -71.9% | |
| All | $6.85B | -71.9% |
Cash and Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $1.93B | at low | |
| 5Y | $1.93B | at low | |
| All | $216.00K | >+9999.0% |
Cash and Cash Equivalents History
FAQ
What is the current annual cash & cash equivalents of MRNA?
As of today, MRNA annual cash & cash equivalents is $1.93B
What is 1-year change in MRNA annual cash & cash equivalents?
MRNA annual cash & cash equivalents is down -33.71% year-over-year
What is 3-year change in MRNA annual cash & cash equivalents?
MRNA annual cash & cash equivalents is down -71.86% over the past 3 years
How far is MRNA annual cash & cash equivalents from its all-time high?
MRNA annual cash & cash equivalents is currently -71.86% below its historical high of $6.85B set on December 31, 2021
How does MRNA annual cash & cash equivalents rank versus sector peers?
MRNA annual cash & cash equivalents is higher than 95.67% of companies in Healthcare sector
When is MRNA next annual earnings release?
The next annual earnings release for MRNA is on
Quarterly Cash & Cash Equivalents
$4.51B$627.00M-12.22%
Summary
- Current Value
- As of today, MRNA quarterly cash & cash equivalents is $4.51B, down -12.22% on
- Historical Performance
- MRNA quarterly cash & cash equivalents is down -34.40% year-over-year, and down -46.03% over the past 3 years
- All-Time High Comparison
- MRNA quarterly cash & cash equivalents is currently -58.00% below its historical high of $10.73B set on
- 3-Year Low Comparison
- MRNA quarterly cash & cash equivalents is at its 3-year low
- Sector Comparison
- MRNA quarterly cash & cash equivalents is higher than 97.78% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash & Cash Equivalents | $4.51B | -12.2% | -34.4% | -46.0% | +37.5% | |
| Annual Cash & Cash Equivalents | $1.93B | – | -33.7% | -71.9% | +717.0% | |
| Price | $33.84 | +26.1% | -19.9% | -82.0% | -72.8% | |
| Quarterly Current Assets | $6.60B | +6.9% | -31.7% | -53.9% | +84.5% | |
| Quarterly Total Liabilities | $2.81B | +7.4% | -27.6% | -65.2% | +48.3% | |
| Quarterly Working Capital | $4.92B | +6.9% | -34.1% | -34.4% | +133.7% | |
| Quarterly Net Income | -$200.00M | +75.8% | -1638.5% | -119.2% | +14.4% |
Quarterly Cash & Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $7.03B | N/A | -35.9% |
| 3Y | $9.90B | N/A | -54.5% |
| 5Y | $10.73B | -58.0% | |
| All | $10.73B | -58.0% |
Quarterly Cash & Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $4.51B | at low | |
| 3Y | $4.51B | at low | |
| 5Y | $4.51B | at low | |
| All | $8,700.00 | >+9999.0% |
Quarterly Cash & Cash Equivalents History
FAQ
What is the current quarterly cash & cash equivalents of MRNA?
As of today, MRNA quarterly cash & cash equivalents is $4.51B
What is MRNA quarterly cash & cash equivalents most recent change?
MRNA quarterly cash & cash equivalents was down -12.22% on September 30, 2025
What is 1-year change in MRNA quarterly cash & cash equivalents?
MRNA quarterly cash & cash equivalents is down -34.40% year-over-year
How far is MRNA quarterly cash & cash equivalents from its all-time high?
MRNA quarterly cash & cash equivalents is currently -58.00% below its historical high of $10.73B set on December 31, 2021
How does MRNA quarterly cash & cash equivalents rank versus sector peers?
MRNA quarterly cash & cash equivalents is higher than 97.78% of companies in Healthcare sector
When is MRNA next earnings release?
The next earnings release for MRNA is on
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
Data Sources & References
- MRNA Official Website www.modernatx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1682852/000168285225000075/0001682852-25-000075-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1682852/000168285225000022/0001682852-25-000022-index.htm
- MRNA Profile on Yahoo Finance finance.yahoo.com/quote/MRNA
- MRNA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mrna